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Recognition within the membraneProtein–protein interactions within the membrane are involved in many vital cellular processes. Consequently,
deﬁcient oligomerization is associated with known diseases. The interactions can be partially or fully mediated
by transmembrane domains (TMD). However, in contrast to soluble regions, our knowledge of the factors that
control oligomerization and recognition between the membrane–embedded domains is very limited. Due to
the unique chemical and physical properties of the membrane environment, rules that apply to interactions
between soluble segments are not necessarily valid within the membrane. This review summarizes our
knowledge on the sequences mediating TMD–TMD interactions which include conserved motifs such as the
GxxxG, QxxS, glycine and leucine zippers, and others. The review discusses the speciﬁc role of polar, charged
and aromatic amino acids in the interface of the interacting TMD helices. Strategies to determine the strength,
dynamics and speciﬁcities of these interactions by experimental (ToxR, TOXCAT, GALLEX and FRET) or various
computational approaches (molecular dynamic simulation and bioinformatics) are summarized. Importantly,
the contribution of the membrane environment to the TMD–TMD interaction is also presented. Studies utilizing
exogenously added TMD peptides have been shown to inﬂuence in vivo the dimerization of intact membrane
proteins involved in various diseases. The chirality independent TMD–TMD interactions allows for the design
of novel short D- and L-amino acids containing TMD peptides with advanced properties. Overall these studies
shed light on the role of speciﬁc amino acids in mediating the assembly of the TMDs within the membrane
environment and their contribution to protein function. This article is part of a Special Issue entitled: Protein
Folding in Membranes.
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Cells sense and respond to environmental stimuli through cell sur-
face transmembrane proteins. Membrane proteins represent about
20–30% of the genome in a variety of different organisms [1–3].
These proteins are capable of transmitting different signals from the
extracellular environment to the intracellular compartments of the
cells. These signals are crucial for many vital cellular processes such
as homeostasis and signal transduction [4–8]. The signal transduction
cascades are usually initiated by ligand binding, which is believed to
induce conformational changes in the receptor that stimulates recep-
tor clustering or oligomerization. Oligomerizationwas found to be ex-
tensively involved in the function of many proteins and therefore it
was not surprising to ﬁnd that deﬁcient oligomerization accounts
for several diseases ranging from cancer to amyloidal diseases
[9–12]. The complexity and sophistication of the biological mem-
brane are overwhelming. The dynamics, versatile composition and
multiple processes that occur simultaneously within this unique envi-
ronment are beginning to be understood. Although our understand-
ing of the activity and organization of the membrane has evolved
tremendously since the relativity simple models of Sanger and Nich-
olson, our understanding of key features and aspects of these areas
is still rather limited. These areas encompass many topics such as pro-
tein assembly within the membrane, trafﬁcking and maintenance of
homeostasis with each of these topics deserving a full review on its
own. Here we will focus on protein–protein interactions within the
membrane milieu which are mediated mainly through transmem-
brane domains (TMD–TMD interactions). We hope to shed more
light on this important and intriguing area by focusing on TMD bio-
logical signiﬁcance, sequence motifs, technical advances in the ﬁeld,
and the complex interaction with the different hydrophobic moieties.2. Sequences mediating TMD–TMD interactions
2.1. Conserved motifs that drive TMD–TMD interactions
Non-covalent association of native TMDswas reported to be medi-
ated by several motifs including: (i) a GxxxG motif, which is the most
common motif for interaction of two TMD helices and was ﬁrst found
in the glycophorin A (GPA) TMD [13–15]; (ii) a heptad motif of leu-
cines through their side-chain residue packing interactions [16];
(iii) polar residues through the formation of hydrogen bonds
[17–21]. A speciﬁc case is the QxxS motif which has been found via
bioinformatical analysis of the transmembrane no. 1 of the bacterial
aspartate receptor (TAR-1), showing that it is highly expressed in
bacterial TMDs, signiﬁcantly more than its anticipated abundance.
This motif has been extended to Polar-xx-Polar motif, in which
polar amino acids include Ser, Thr, Glu, Gln, Asp, and Asn [21,22];
(iv) An Aromatic-xx-Aromatic, in which Trp gives the best dimeriza-
tion; (v) a Gly zipper (GxxxGxxxG) motif, found as the primary pack-
ing interface for the TMD of the myelin protein zero, which is the
major integral membrane protein of peripheral nerve myelin in
higher vertebrates [23]; (vi) A Leu zipper motif that controls the di-
merization of the transmembrane domain of the platelet-derived
growth factor β-receptor (PDGFβR) receptor [24], or the dimeric re-
ceptor tyrosine kinase DDR1 [25]; and (vii) A Ser/Thr rich sequenceswhich was found by a randomized library of TMD helices that was
generated, in which glycine was omitted [20]. This motif was found
later in the transmembrane domain of Hepatitis C virus (HCV) non-
structural protein 4B (NS4B), which is an integral membrane protein,
playing an important role in the organization and function of the HCV
replication complex. However, the involvement of additional motifs
or key factors that mediate protein–protein interactions within the
membrane merit needs further investigation.2.2. The role of polar residues in TMD–TMD interaction
Generally speaking, once proteins become inserted into the mem-
brane and their secondary structure is created, tertiary contacts are
formed between TMD helical segments. This process is believed to
be largely driven by the maximization of Van der Waals contacts
through complementary knobs-into-holes type interactions
[13,14,26,27]. However, it became evident that interhelical associa-
tion can also be stabilized by formation of hydrogen bonds. In certain
geometries, a single membrane-buried hydrogen bond may contrib-
ute as much stabilization energy as that provided by the sum of the
interhelical Van derWaals contacts along the full lengths of two inter-
acting TMDs [28]. Such hydrogen bonding is formed between a pair of
TMDs through one or more polar residues.
The signiﬁcance of polar residues for the association of TMDs has
been studied both in vitro, by examining TMDs synthetic peptides
with polar residues in their sequence, and in vivo, by analysis of de
novo designed TMD helices [17–20]. These studies revealed that
amino acids containing two polar side-chain atoms (such as Asn
and Gln) have a greater tendency to drive TMD association than res-
idues containing only one polar side-chain atom (Thr or Ser) [17–20].
The amino acids with two polar atoms can act simultaneously as a
good hydrogen bond donor and acceptor and therefore form a more
stable oligomer than the polar residues Ser and Thr, which contain
only one polar side-chain atom. Nevertheless, the presence of polar
residues within the TMD is not always sufﬁcient for TMD assembly
and depends on the exact position of the polar residue along the
TMD [29]. When discussing the effect of Glu and Asp within the mem-
brane environment, it is important to bear in mind that the core of the
biological membrane has a low dielectric constant. This imposes pro-
tonation of the carboxylic group. Thus, the Glu and Asp residues are
not charged within the membrane environment but rather contain
two polar side-chain atoms such as Gln and Asn [17–20].
Von-Heijne and collaborators [30], utilized in vitro translation of
model integral membrane protein constructs in the presence of
rough microsomes, and showed that Asn-Asn or Asp–Asp-mediated
interactions with a neighboring transmembrane helix can enhance
the membrane insertion efﬁciency of a marginally hydrophobic trans-
membrane segment. Their data suggest that inter-helix hydrogen
bonds can form during Sec61 translocon-assisted insertion and thus
could be important for membrane protein assembly.
It has been also found that non-polar-to-polar mutations in the
TMDs of membrane proteins are associated with several diseases
[11,31]. For example, a speciﬁc Val→Glu mutation within the TMD
of the ErbB2 oncogene product (Neu) [27,32] is known to induce
ErbB2 dimerization and activation [33,34]. Such activation of ErbB2
has been detected in a large fraction of breast and ovarian cancers
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the QxxS motif, by non-polar residues signiﬁcantly reduced the di-
merization ability of Tar-1 [21,35,36]. The role of the polarity of
amino acids within the QxxS motif has been also extensively studied
and is discussed in detail in the proceeding paragraphs.
2.3. The role of positively charged residues in TMD–TMD interaction
Positively charged amino acids, which are localized within the
TMDs of membrane proteins, are known to have both functional
and structural roles in the activity of these proteins. Examples include
their involvement in substrate recognition [37], their ability to deter-
mine the electrogenicity of theH,K-ATPases [38], and their involvement
in mitochondrial citrate transport [39]. Moreover, mutations that intro-
duce positively charged residues into TMDs have been previously
shown to be involved in human genetic diseases [31,40], including cys-
tic ﬁbrosis, Charcot–Marie–Tooth disease, Wilson's disease, dominant
rental hypomagnesaemia [31,40,41], and many others. TMDs are
known to be involved in self- and hetero-assembly of membrane pro-
teins. The charged amino acids may also affect the structure of the pro-
tein. Therefore, such mutations might interfere with the interactions
and proper assembly of the TMDs. Nevertheless, it seems that despite
signiﬁcant progress in understanding the mechanism of TMD–TMD
interactions, the direct effect of positively charged residues on these
interactions have not been extensively studied in vivo.
As discussed above, the core of the biological membrane has a low
dielectric constant. This imposes the alteration of physical and chemical
properties of all polar amino acids [18,19]. As a result, Arg and Lys can
either stabilize dimerization by forming hydrogen bonds or shift the
equilibrium toward monomers by inducing repulsion. This can be
affected by their protonation state. It is most probable that positively
charged residues have a disruptive effect on dimerization only when
they are localized to the interacting surfaces of the helices, as was pre-
viously shown by synthetic peptides derived from the TMD region of
the sodium pump γ subunit [11]. Interestingly, most of these disease-
causing mutations introduce Arg and not Lys into the TMDs. Moreover,
evidence has been presented that positively charged residues interact
with negatively charged ones in the membrane [42].
In another study, a single amino acid substitution, from Ala to Lys,
within the TMD No 1 of the full-length Tar receptor, resulted in the loss
of the chemotaxis function induced by the protein. However, neither
the membrane integration nor the aspartate-binding ability of the
mutated receptor has been affected [43].
Recently, Hristova and Wimley [44] reviewed the current knowl-
edge about the energetics of Arg insertion into the bilayer hydrocar-
bon core, and discussed discrepancies between experimental and
computational studies of the insertion process. While simulations
suggest that it should be very costly to place Arg into the hydrocarbon
core, experiments, such as those described above, show that Arg is
found there. Nevertheless, both types of studies suggested that Arg
insertion into the bilayer involves substantial bilayer deformation,
with multiple hydrogen bonds between the Arg guanidinium group
and lipid polar groups. An explanation for such a difference might
be due to the fact that simulations overestimate the cost associated
with bilayer deformation and underestimate the ability of the bilayer
to adapt to charged and polar groups.
2.4. The role of aromatic residues in TMD–TMD interaction
Aromatic residues serve as key structural elements that mediate
the molecular recognition and the self-assembly of many membrane
proteins including amyloid polypeptides, bacterial toxins and others
[45–49]. Theoretical and empirical studies have shown that aromatic
rings tend to form high-order clusters of four different types: parallel
displaced, T-shaped, parallel staggered or Herringbone. All these four
geometries are referred to as π–π interactions or π-stacking [50–52].Studies have shown that a mutation of a single aromatic amino acid
can abolish the ability of the corresponding amyloid peptide to form
amyloid ﬁbrils [53]. Sequence analysis of membrane immunoglobulin
and T-cell receptor revealed highly conserved aromatic amino acids
within the TMDs of these proteins. These may point out to the in-
volvement of these residues in TMD–TMD interactions [54]. Further
support for this assumption comes from the studies by Langosch
and coworkers who demonstrated, using a randomized TMD library,
that Trp is enriched in self-interacting TMDs containing a heptad re-
peat backbone sequence [55]. In another study TMD–TMD interac-
tions were shown to be mediated by π–π interactions of parallel
aromatic residues as in the case of theWxxWmotif. In this case stacking
of the Trp aromatic residues serves to stabilize the TMD–TMD interac-
tion [21,35]. Amodiﬁcation of this interactionwas later on shown to in-
volve cationic–π interactions. In this case, a motif composed of Ala and
Ile was replaced in speciﬁc positions with charged or hydrophobic res-
idues. This work shows that the interaction between the charged resi-
dues and the hydrophobic ones greatly enhance dimer formation [56].
3. Strategies for studying TMD–TMD interactions within
membrane proteins
Despite the abundance and importance of TMD–TMD interactions,
biochemical research trying to elucidate their structure function rela-
tionship has been facing many technical obstacles [57]. One major ob-
stacle is puriﬁcation and crystallization. Due to their hydrophobicity,
membrane proteins are relatively insoluble in aqueous solution, mak-
ing detergent choice a key factor in this process. Most of the 231
unique membrane protein structures (as of 3/2010) are of bacterial
membrane proteins (MPs) expressed in bacteria, or eukaryotic MPs
from natural sources. However eukaryotic membrane proteins, espe-
cially those with more than three membrane crossings rarely suc-
cumb to any suitable expression in bacterial cells [58–60]. As helix–
helix interactions within the membrane are many times ﬂexible by
nature, it is hard to follow such interactions in the intact protein or
within a rigid crystal (reviewed by [61]). In order to address issues
of ﬂexibility in interaction within the membrane milieu, a variety of
techniques were developed in recent years as summarized below.
3.1. The ToxR, TOXCAT and GALLEX systems
The ToxR system [62] can detect weak protein–protein interac-
tions within the membrane environment of E. coli. The method is
based on the functional organization of a plasmid that encodes the
ToxR-TM-MalE chimeric protein, in which: the cytoplasmic domain
ToxR is linked via a TMD of choice to the periplasmic MalE moiety.
The ToxR transcription activator is a membrane protein with a short
predicted TMD. External stimuli are thought to induce oligomeriza-
tion of the ToxR. The oligomeric ToxR molecule binds to a tandemly
repeated DNA element found within the ctx promoter, thus initiating
transcription of the ctx genes (lacZ in the indicator cells) (Fig. 1A). In
the ToxR system the TMD of the ToxR is replaced by the studied TMD.
The amount of homodimerization is quantiﬁed by measuring the ac-
tivity of the β-galactosidase (β-Gal) reporter gene and dividing the
activity by the cell content (OD590) (Miller units). The results are nor-
malized between the positive and negative controls, ToxR-GPA and
ToxR-A16, respectively [42,62].
The ToxR system was designed to detect homo-oligomerization,
but was modiﬁed further to detect hetero-oligomerization as well
[63]. The idea is to exogenously introduce TMD peptides into the
ToxR system and to monitor their effect on the level of oligomeriza-
tion, detected by the activity of β-galactosidase (Fig. 1B). Interaction
between a TMD peptide and the TMD that is inserted in the chimera
protein (ToxR-TM-MalE) will result in reduction of the initial oligo-
merization signal [63]. The reduction results due to the creation of a








Fig. 1. (A) Schematic illustration of the ToxR homo-oligomerization system. The
association of the TMDs activates ToxR, which only then can bind the ctx promoter and
can initiate the lacZ transcription process [62]. (B) Schematic illustration of the ToxR
hetero-oligomerization system. Hetero-association of the exogenous peptides with the
TMDof the ToxR systemprevents the activation of ToxR by shifting the equilibrium toward
monomeric ToxR, thus reducing lacZ transcription and hence its signal. The inserted TMD
of choice is illustrated as a blue cylinder and the exogenously added TMD peptide (e.g.
Tar-1) is a pink helix [63].
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dues are added to their N and C-termini. These Lys tags confer
water solubility to many of the hydrophobic TMDs without affecting
correct oligomerization and insertion into the membrane [64–66].
Nevertheless, stock solutions of highly insoluble TMDs are prepared
in DMSO and added to the cells such that the ﬁnal concentration of
DMSO does not exceed 2%.
A similar and more sensitive system had been developed by Russ
and Engelman and is based on the expression of the chloramphenicol
acetyltransferase therefore termed TOXCAT [67]. Both systems have
been widely used, with the TOXCAT developed to assess changes in
free energy as a result of TMD–TMD dimerization, as described above.
To assess hetero-assembly in a more direct way, another system
has been developed —the GALLEX system ﬁrst reported by Schneider
and Engelman [68]. This approach is similar to the previous methods
but is based on a mutated LexA repressor that consists of two sub-
units transcribed from two different plasmids. In this system, β-Gal
is constitutively expressed by E. coli cells. The self-interacting GpA is
used as a positive control yielding high repression of β-Gal expression
and the mutated GpA G83I is used as a non-interacting pair yielding
maximal β-Gal activity. This system was recently used to assess
changes in the membrane ﬂuidity on TMD–TMD interaction (see de-
tails in the proceeding paragraphs).
3.2. Analytical ﬂuorescence resonance energy transfer (QI-FRET)
QI-FRET has been recently developed to follow dynamic TMD–TMD
interactionswithin themembranemilieu [69]. In this technique, plasma
membrane vesicles and twoﬂuorescently tagged TMDs are scanned andvisualized by confocal microscopy. Statistical analysis of the FRET
between the two ﬂuorophores can indicate the strength of the in-
teraction. Moreover, this method can be used to calculate free en-
ergy differences between speciﬁc mutants as has been shown for
GpA TMDs.
3.3. Stop ﬂow ﬂuorescence analysis
A stop ﬂow ﬂuorescence analysis has been demonstrated by Tang
et al., [70]. This assay is based on the ﬂuorescence of two distinct
probes Trp and Phe-cn that are present in a model TMD peptide.
The ﬂuorescence of both probes is sensitive to the environment.
Phe-cn is also sensitive to the protein or peptide conformation.
Thus, following the rapid mixing of peptides with POPC/POPG vesicles,
the kinetics were observed (through the above mentioned probes)
and revealed three distinct phases: membrane binding, insertion and
dimerization, with the latter being in the time scale of seconds.
3.4. High throughput combinatorial peptide library
He et al. [71] utilized high throughput selection approach to study
the single TMD of a receptor tyrosine kinase (RTK), in order to identify
speciﬁc dimerization sequence motifs that bind to this TMD. For that
purpose they designed a 3888-member combinatorial peptide library
based on the TMD domain of Neu (ErbB2) as a model RTK. The library
containsmany closely related, Neu-like sequences, including thousands
of sequences with known dimerization motifs. They then used an
SDS-PAGE-based screen to select peptides that dimerize better
than the native Neu sequence, and assayed the activation of chimeric
Neu receptors in mammalian cells with TMD sequences selected in
the screen. Interestingly, despite the very high abundance of
known dimerization motifs in the library, they found only a very
few dimerizing sequences. One of the advantages of this approach
is that it yields direct information about the speciﬁcity of such
TMD–TMD interactions.
3.5. Molecular dynamics simulations and computational design
The lack of sufﬁcient structural data has led many researchers to
use molecular dynamics (MD) simulations in order to obtain insights
about different aspects of the membrane protein interface (see review
[72]). In a recent study Zhang and Lazaridis [73] tested the inﬂuence
of a non-interfacial residue (Lys 40) on the association of the TMDs of
the major coat protein (MCP) from the bacteriophage M13. By using
MD simulation and comparing MCP, GPA and different sequence
chimeras of their TMD, the researchers were able to show that this
speciﬁc polar residue has a tremendous impact on the association
ability of the MDP TMDs. The usage of MD simulations allows for
an explanation of this phenomenon: simulated protonation and
deprotonation of Lys 40 caused major conﬁguration changes within
the tilt and position of the TMD relative to the membrane bilayer.
Thus, the researchers conclude that different ﬂanking non-interfacial
ionizable residues in the TMD can inﬂuence dimer association by
inducing large conformational changes of TMDs [73].
Very recent studies compared the self-assembly dynamics of Leu-
kocyte integrin αβ2 and αβ3 TMD helices in a model membrane
using coarse-grained MD simulations [74]. They found that although
αβ3 TMD helices associate more easily, packing is suboptimal. In
contrast, αβ2 TMD helices achieve close-to-optimal packing. This
suggests that αβ2 TMD packing is more speciﬁc, possibly due to the
inter-helix hydrogen bond. Disruption of this inter-helix hydrogen
bond in αβ2 via the β2T686G mutation results in poorer association
and a similar proﬁle as αIIβ3.
The de novo design of protein-binding peptides by computational
design has been also described. For example, Sammond et al. [75]
used as a model system the GoLoco motif from the G-protein regulator
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G-protein R subunit Gα(i1) in its inactive, GDP-complexed state.
They described a strategy that iterates between structure and se-
quence optimization to redesign the C-terminal portion of the
RGS14 GoLoco motif peptide so that it adopts a new conformation
when bound to Gα(i1). An X-ray crystal structure of the rede-
signed complex closely matches the computational model, with a
backbone root-mean-square deviation of 1.1 Ε.
In another case, MD simulations combined with conformational
considerations were used in order to probe TMD–TMD interactions
without prior experimental data. The researchers tested their model
against an experimental data of GpA dimers and further used it to
probe the association of ErbB2 and ErbB3. Using this method they
were able to suggest conformational considerations for the associa-
tion between these two receptors under different conditions
[76,77]. This system can prove valuable when there is lack of experi-
mental data and as a general guideline for probing unknown
interactions.
Another example for the usage of MD simulations is to compare
structural aspects of different dimerizing motifs. In an article by Sal-
Man et al., a novel dimerizing motif WxxW was identiﬁed and com-
pared by MD simulations to the already known dimerization motif
QxxS. Using this approach it was revealed that the backbone of the
TMD constrains theWxxWmotif while it has little effect on dimeriza-
tion of the QxxS motif [35].
3.6. Bioinformatic tools
Large scale bioinformatical scanning of TMD libraries can be a use-
ful tool to identify novel interacting elements or motifs. Engelman
and coworkers used a novel formalism called TMSTAT to calculate
the expectancies of all pairs and triplets of residues in individual se-
quences, taking into account differential sequence composition and
the substantial effect of ﬁnite length in short segments. The major
ﬁnding was patterns of small residues (Gly, Ala and Ser) at i and
i+4 found in association with large aliphatic residues (Ile, Val and
Leu) at neighboring positions (i.e. i+/−1 and i+/−2). The most
over-represented pair is formed by two glycine residues at i and
i+4 (GxxxG, 31.6%), and it is strongly associated with the neigh-
boring β-branched residues Ile and Val [78]. Another study utilized
this approach to identify cationic interaction together with GxxxG
motifs as possible interacting elements [42]. In this study, GxxxG with
either K/R or D/E at positions −10 to −1 away were examined for
their natural occurrence within TMD sequences. The data revealed
that some of the sequences were signiﬁcantly over expressed in the
natural libraries. Testing their ability to interact showed that at least
one pair was able to promote efﬁcient heterogenic interactions. In
another study statistical analyses were undertaken for putative
transmembrane α-helices obtained from a database representing the
subset of membrane proteins available in Swiss-Prot. The average
length of a transmembrane α -helix was found to be 22–21 amino
acids with a large variation around the mean. The same study also
described the preferred positions for hydrophobic, polar, tyrosin and
trypotophan [79]. Other examples include the identiﬁcation of the
QxxS, and the WxxW dimerization motifs [21,35].
4. Examples signifying the importance of TMD–TMD interactions
for protein function
4.1. The EGF receptor
One of the most investigated examples is the family of ErbB
growth factor receptors. This family of receptor tyrosine kinases con-
sists of four members that through their combinatorial association are
able to recognize a wide array of ligands [80,81]. Although the main
driving force for their speciﬁcity in binding their ligand is therecognition by the extracellular regions, it was also postulated that
the TMD of these proteins are able to self-associate and inﬂuence bi-
ological activity. For example, a speciﬁc Val→Glu mutation within
the TMD of the ErbB2 protein is known to induce uncontrolled dimer-
ization and activation of the receptor, resulting in production of an
oncogene (Neu) [32–34]. Furthermore, Mendrola et al., [27] has
shown that the TMDs of these receptors can self-associate where
the association was the strongest for ErbB4 and the weakest was
ErbB3. Further analysis of these interactions revealed that this inter-
action is mediated by several GxxxG motifs and that their role is in
both hetero- and homodimerization. While it was established that
the GxxxG in the C terminus TMD of ErbB1 and ErbB2 was involved
in homodimerization, Gerber et al., [82] showed that another GxxxG
motif located at the N terminus of the TMD is involved in hetero-
assembly between ErbB1 and ErbB2. Thus, it is proposed that these
regions account for the ﬁne tuning of these receptors in response to
different ligands.
In a different aspect, the dimerization of these regions was also
suggested to increase the stability of these proteins. The oncogenic
mutation V644E in the rat homolog of ErbB2 was shown to have a re-
duced ability to self-associate in membranes in comparison to the wt
TMD [83]. However the mutant isolated TM domain has been shown
recently to cross-linked to a higher degree than the wild-type TM do-
main in cells, which contradicts the ToxCAT data [84]. In another re-
cent study by Chen et al., the researchers calculated the decrease in
the free energy due to TMD dimerization and found it to be in the
order of 2.5–3 kcal/mol [85]. Similar results were observed in studies
of GpA, correlating free energy changes due to dimerization with in-
creased protein stability [86]. Taken together, these ﬁndings suggest
that such energetic changes have a signiﬁcant inﬂuence on biological
activity.
4.2. The integrins
Integrins are a family of membrane receptors that mediate cell ad-
hesion. Several studies have shown that their TMDs are capable of
forming oligomers and that these interactions are based on the
GxxxG motifs present within these regions [87]. Mutational analysis
revealed that the interaction between the TMDs of the integrins
αIIBβ3 is sensitive to other residues as well, probably allowing for
subtle conformational changes within this region to affect stability
([88] see below). In a different study, Yin et al., showed that an exog-
enous peptide that corresponds to the TMD of the integrin αIIb is able
to activate these integrins in vitro [89]. The model proposed for integ-
rin activity suggests that in their resting state, the heterodimer TMDs
are packed closely together, while in their activated state the hetero-
dimer TMDs dissociated and there is a greater tendency towards
homodimer formation. By adding an exogenous TMD peptide that is
capable of interacting with the native protein TMD, interfering with
heterodimer formation, the equilibrium is shifted towards the acti-
vated state. As integrins are plasma membrane proteins important
for cell adhesion, such a peptide was shown to activate platelet aggre-
gation in a ligand independent fashion.
In depth examination of the interaction between the αIIb and β3
was performed to conﬁrm this model [87,90]. In these studies muta-
tional analysis was used to assess the heterodimer formation ability,
as well as the effect of such mutations on the activation level of
these proteins. The ﬁndings that β3 mutations along the TMD hetero-
dimer interface reduce heterodimer association but activate the local
adhesion kinase, a down-stream effector of the integrin receptor, sup-
port this theory. Thus it seems that the interface of these proteins is
optimized for heterodimer assembly. Further mutational analysis
done by Li et al., [88] showed that the interaction between the
TMDs of the integrins αIIBβ3 is sensitive to other residues as well.
In this speciﬁc case the important residues are at positions −1 and
+4 from the GxxxG motif, allowing for ﬁne tuning of this interaction.
Heterodimer 
Change in crossing angle 
Homodimer 
Helices Cross at an angle 
Fig. 2. A model describing the assembly of an all-L helix with its all-D enantiomer. The
surface of interaction between the two all-L helices is seen in pink. When one of the
chains is replaced with and all-D enantiomer TMD the interaction surfaces cross each
other and assembly is impossible. However, by changing the tilt angle between the helices
it is possible to re-orient of the interaction surfaces to face each other [97,100].
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of the integrins reveals that all mutations along the β3 interface are
associated with reduced heterodimer stability [90].
4.3. The bacterial aspartate receptor (Tar)
The Escherichia coli aspartate receptor (Tar) is one of the known
examples of proteins whose TMD is involved in oligomer stabilization.
This receptor is one of the main chemotaxis receptors found in bacteria
and it mediates chemotactic response, mainly to aspartate, glutamate,
and maltose [91–93]. Tar forms a homodimer complex in which each
subunit is composed of two TMD helices (Tar-1 and Tar-2) separated
by a substantial periplasmic domain [94,95]. Disulﬁde cross-linking
studies suggested that the Tar-1 TMD interacts with the corresponding
Tar-1' TMD of another Tar protein to form the dimer. There is no direct
contact between the two Tar-2 helices in the Tar dimer [94]. In support
of this, a synthetic peptide corresponding to the Tar-1 TMD could form
an SDS-resistant homodimer, whereas the Tar-2 TMD remains mono-
meric [64]. The Tar-1 does not contain the well-characterized GxxxG
motif. Studies utilizing ToxR systemand various biophysical approaches
revealed that the 22QxxS25 sequence is the minimal motif sufﬁcient for
Tar-1 TMD–TMD self-assembly. These two polar residues are located on
the same helix interface and most probably stabilize association by
forming hydrogen bonds. Interestingly, creating a GxxxGmotif, instead
of the polarmotif, almost completely abolished dimerization. Swapping
positions between twowild-type polar residues did not affect dimeriza-
tion, implying a similar contribution from both positions [22]. More-
over, Sal-Man et al. [21] demonstrated that this short polar motif is
sufﬁcient to induce dimerization of a non-dimerizing backbone
(containing Leu and Ala residues). Statistical analysis of a bacterial
TMD database revealed that this motif appears to be signiﬁcantly
over-represented compared with its theoretical expectancy [22].
Taken together, these results suggest that the QxxS motif plays a
general role in TMD assembly. Mutational analysis was then performed
in order to examine the involvement of speciﬁc residues within this
motif in TM self-assembly. One or both polar residues (Gln and Ser),
were mutated to various amino acids (polar, positively charged, or
aromatic). The data revealed that substitution of polar residues at
positions 22 and 25 for non-polar residues dramatically impaired the
self-association ability of Tar-1. However, replacement of the original
polar residues by other polar amino acids preserved or increased
assembly depending of the number of hydrogen bonds created: Gln
and Asn which can act simultaneously as a good hydrogen bond
donor and acceptor, induced a stronger association than the polar resi-
dues Ser and Thr, which contain only one polar side-chain atom [22].
Furthermore, introducing an arginine into the Tar-1 interacting inter-
face signiﬁcantly reduces its ability to self-associate, thus implying
that arginine, which contains three polar atoms within the low dielec-
tric environment of the membrane, shifts the oligomer equilibrium
towards monomers by inducing repulsion [96].
5. The role of chirality in membrane protein assembly: peptide
inhibitors as a case study
The current dogma asserts that chirality is vital for proper assem-
bly of proteins. However, this is mainly due to observations of soluble
proteins. Challenging this dogma by short interfering TMD peptides
containing D- and L-amino acids suggests that the membrane environ-
ment allows for leniency in the assembly of TMDs with mirror images
and even diastereomers with both D- and L-amino acids in the same
peptide. This has been demonstrated for the ﬁrst time by studies
showing that the all-D amino acid GPA transmembrane domain, as
well as its two all-D amino acids mutants, speciﬁcally associated
with an all-L wildtype GPA TMD within the membrane of E. coli. MD
techniques revealed a possible structural explanation to the observed
interaction between all-D and all-L transmembrane domains. A verystrong correlation was found between amino acid residues at the
interface of both the all-L homodimer structure and the mixed L/D
heterodimer structure, suggesting that the original interactions are con-
served. The results suggest that GPA helix–helix recognition within the
membrane is chirality independent [97].
In a second study by Gerber et al. [98] the replacement of two Val
within the TMD of GpA with their D enantiomers was used to assess
the role of chirality in this dimerization of GPA TMDs. Although this
replacement caused major alteration in the structure of the peptide,
it was still active and was able to interact with its respective TMD.
The heterodimer seems to maintain all the interactions within the
native GPA homodimer. Thus, the dimerization of GPA through its
TMD proved sterically tolerant to assembly with its mirror image
TMD [98].
In a third study, Gerber et al. investigated the role of chirality in
the assembly of the TMDs of the T-cell receptor (TCR) complex. This
work was based on a peptide that was previously reported to uncou-
ple TCR-α chain from CD3 and by that inhibits the T-cell activation
signal [99]. When testing different enantiomers of this peptide, both
all-L and all-D peptides were found to co-localize with TCRα in the
immune synapse and inhibit antigen-speciﬁc T-cell activation. The in-
hibition is carried out in a sequence speciﬁc manner, as demonstrated
by an inactive 2G CP mutant. In vivo, both all-L and all-D CP enantio-
mers inhibited adjuvant arthritis (AA) in rats [100]. Furthermore,
similarly to the case of GPA TMD, the secondary structure of CP was
disrupted by replacing two positive residues, needed for the interac-
tion of CP with the TCR complex, by their D-amino acids enantiomers.
Various biophysical and biological studies revealed that the diastereo-
mer, despite its signiﬁcantly altered structure, preserved its ability to
bind to the native CP and to be effective also in vivo: it inhibited AA in
rats and delayed type hypersensitivity in BALB/c mice. Importantly,
the new diastereomer manifested greater immunosuppressive activi-
ty than wild-type CP, both in vivo and in vitro, which can be attributed
to the greater solubility and resistance to degradation of peptide
[101].
Using a similar approach Sal-Man et al. showed that a D enantio-
mer TMD peptide of the E. coli aspartate receptor was able to inhibit
chemotaxis mediated by this receptor [36]. Finally, a D analogue of
TMD number 5 of the multidrug resistant transporter P-glycoprotein
was shown to inhibit the efﬂux activity of this transporter. This inhib-
itory activity was sufﬁcient to sensitize doxorubicin resistant cancer
cells to this speciﬁc drug [102].
What is the mechanism that allows for chirality independent
TMD–TMD interactions? Remarkably, a simple rotation of the tilt
angle may compensate for the replacement of an all-L chain with an
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the model of GPA, is built of two all-L chains crossing at an angle to
one another. A replacement of one chain to its all-D enantiomer will
result with an interaction surface, which has the same sequence as
the wild type, although in mirror image orientation. By changing
the tilt angle between the two helices, it is possible to bring the inter-
action surfaces to a similar orientation as in the wild-type homodimer
(Fig. 2). A similar approach can explain TCR inactivation by these
D-analogue peptides (Fig. 3).
The surprising efﬁciency of the all-D peptides might have important
therapeutic implications, since D-peptides are not hydrolyzed by
endogenous proteases leading to an increased half life time in the
biological system of interest. Moreover, the fact that these are highly
hydrophobic peptides that are rapidly sequestered to the hydrophobic
membrane interface might also affect and potentially increase their
retention time within the body.6. Membrane inﬂuence on TMD–TMD interactions
One of the main difﬁculties in studying TMD–TMD interactions is
the usage of detergents to assess different aspects of these interac-
tions. It is becoming apparent that in some cases there are large dif-
ferences in the state of the protein under investigation in micelles
and membranes as can be reﬂected by their simulated structure
(see [61]). In an attempt to systematically explore such differences
in dimerization propensity in micelles vs. biological membranes,
Doung et al. compared GpA dimerization by TOXCAT analysis to sed-
imentation analysis in SDS [86]. An important observation in this
study was that a decrease in the hydrophobicity of the TMD of GpA
lowers dimer stability under solvation by detergent, but does not
affect dimer stability in the biological membrane as revealed by
TOXCAT. Thus, the researchers concluded that the TMD within the
detergent assumes a different conformation that would be less favor-
able under the 2-step model of insertion into the biological lipid bi-
layer [103]. Earlier, when developing the TOXCAT assay, Russ and
Engelman reported on another discrepancy between biophysicalBA
D L L  L
Fig. 3. The change in tilt angle accommodates for all-L replacement with all-D TMD. (A) GP
blue with the “interaction motif” labeled in red. The all-D helix is in pink with the “interactio
procedure [63]. The all-L helix is in blue with the “interaction motif” labeled in red. (C) The T
is known to interact with CD3δ and CD3ζ through salt bridges. A is presented for the 3α-heli
helix is tilted with respect to the CD3 helices. (D) The all-L TCRα with all-D TCRα are reorie
positions in space as the original all-L TCRα side chains [100].analysis and this E. coli based reporter system [67]. In this study the
researchers observed that while Tyr substitutions at non-interfacial
positions of the GpA TMDs were none-disruptive in the TOXCAT
assay, such mutations had a disruptive effect on dimerization as
revealed by SDS-PAGE.
Membrane physical aspects such as ﬂuidity can also affect TMD–TMD
interactions. In a recent study byAnbazhagan et al., it was shown that the
local anesthetic phenylethanol decreased the order of the acyl chains
within amembrane bilayer, thus increasing itsﬂuidity. As a consequence,
TMD–TMD dimerization of the GpA, ErbB2, ErbB3 and FGFR TMDs was
signiﬁcantly lower as determined by the TOXCAT assay [104]. This
study suggest that affecting the membrane property, and indirectly
affecting protein dimerization, might be an explanation for the mode
of action for anesthetic, which is still an open question.
Another intriguing aspect of TMD–TMD interactions involves lipid
solvation. In a study by Cunningham et al., an inverse correlation was
observed between lipid accessibility (i.e. lipid protein interface) and
dimerization ability, as deﬁned experimentally by TOXCAT assays. In
this study, the Val at positions 80 and 84 of the GPA were mutated
to other hydrophobic residues such as Ile, Leu and Ala in different
combinations. Although these substitutions were adjacent to the
GxxxG motif, some had a large impact on TMD–TMD interactions,
with some pairs giving even better dimerization than the Val-Val wt
pair. Based on the two step model of TMD assembly mentioned
above and the structural arrangement of the different mutants, the
researchers conclude that the increased ability or inability of the
lipid environment to solvate the α-helical structure may greatly
decrease or increase the helix–helix interactions, respectively. In other
words, the more the side chains are exposed to the lipid interface they
have less ability to establish TMD–TMD interactions.7. Short TMD peptides as novel inhibitors of membrane
protein function
Due to the biological importance of TMD regions, much research
has focused on the ability of exogenously added peptides to inﬂuenceC 
D
 
A heterodimer structure after molecular dynamics procedure [97]. The all-L helix is in
n motif” is labeled in green. (B) GPA homodimer structure after the molecular dynamics
CR complex consists of several TMDs, nevertheless it follows the same rules. The TCRα
ces and oriented them in such a manner to allow the salt bridges to form. The all-L TCRα
nted by changing the tilt angle, until the Arg and Lys side chains were placed at similar
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on the ability of these short TMDs to bind their respective TMDwithin
the membrane and affect their assembly or dimerization (for a more
detailed review on this approach see Ref. [57]). In addition to the
studies on integrins (above), other reports showed that exogenously
added TMD peptides inﬂuence the dimerization of several other
TMDs such as the TMD of GPA and the TMDs of members from the
growth factor receptor family ErbB [63,82]. As the TMD–TMD interac-
tions within the ErbB family were shown to be important for protein
stability, peptide inhibition of the ErbB2 signaling was also shown
and is dependent on the GxxxG of the peptide [85,105].
Other examples of TMD peptides that inhibit a membrane protein
function are those of the phospholamban peptide that perturbed the
SERCA Ca++ channel [106], the core TCRα TMD (Core peptide, Cp)
that inhibited the T-cell activation through the TCR complex [21] and a
TMD peptide that inhibited the multidrug transporter P-glycoprotein
in a chiral independent manner ([102], see below). The design of
β-peptide foldamers targeting the TMDs of complex natural membrane
proteins has been a formidable challenge. Degrado and coworkers [107]
designed a series of β-peptides to stably insert in TMD orientations in
phospholipid bilayers. The secondary structures and orientation of the
peptides in the phospholipid bilayer was characterized using biophysi-
cal methods. Computational methods were then devised to design a
β-peptide that targeted a TMD helix of the integrin α(IIb)β(3). The
designed peptide (β-CHAMP) interacts with the isolated target TMD
of the protein and activates the intact integrin in vitro.
In summary, this review summarizes our knowledge on the
sequences mediating TMD–TMD interactions, as well as the speciﬁc
role of polar, charged and aromatic amino acids in the interface of the
interacting TMD helices. Strategies to determine the strength, dynamics
and speciﬁcities of these interactions include both experimental
and computational approaches. Importantly, the contribution of the
membrane environment to the TMD–TMD interaction is also discussed.
Besides shedding light on the role of speciﬁc amino acids in mediating
TMDs speciﬁc assembly, short exogenously added synthetic TMD
peptides can inﬂuence in vivo the dimerization of intact membrane
proteins involved in various diseases. Finally, the ﬁnding of chirality
independent TMD–TMD interactions allows for the design of novel
short D- and L-amino acids containing TMD peptides with advanced
properties.
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